|
Wang ZK, Chow SC, Chow MSS. Bioequivalence Assessment for Intranasal Rapid-Acting Drug Products. J Clin Pharmacol 2026;66(1):e70138. This work proposes a novel bioequivalence approach for rapid-acting drug products that emphasizes early drug exposure and therapeutic onset. If adopted by regulatory agencies, it could facilitate more efficient development and approval of rapid-acting therapies, potentially improving patient access to innovative and affordable treatments. Dr. Moses Chow is the senior author of this work, in collaboration with his former Postdoc fellow Dr. Kevin Wang (now an Associate Professor at UCI) and Dr. SC Chow, Professor of Biostatistics & Bioinformatics, Duke University School of Medicine.
Dr. Chow also presented an invited lecture “The Pharmacist as Clinician and Innovator: Improving Healthcare in the Era of AI,” at the Sun Yat-sen University International Pharmacy Conference on Aug. 8, 2026. The lecture highlighted how pharmacists can advance health care through evidence-based practice, translational research, innovation, and the responsible use of AI, while emphasizing the enduring importance of truth, benevolence, and beauty in professional service and human well-being.
Drs. Skoglund and Hean, together with their 2026A Academia APPE students, received the Education & Training PRN Best Poster Award at the 2026 American College of Clinical Pharmacy (ACCP) Virtual Poster Symposium for their poster, "Description of Workload Related Residency Components Among California Postgraduate Year One and Two Pharmacy Residency Programs." The project was completed in collaboration with their APPE students, Lauren Yi and Saira Pacheco, who served as the live virtual presenters during the symposium.
Dr. Ligang Liu's publications and poster presentations:
Lin Y, Li H, Nahata MC, Zhang C, Ramey OL, Liu L. Treatment patterns and barriers to care among US adults with co-occurring substance use disorder and mental illness. Am J Psych 2026. https://doi.org/10.1176/appi.ajp.20251314
Liu L, Xiong G, Zhao H, Shi H, Liang M, Nahata MC. Trends in weight loss attempts and strategies among US adolescents with overweight or obesity. Obesity (Silver Spring). Published online April 5, 2026.
Liu L, Tao H, Zhao H, Wang J, Wang K, Xiong G, Nahata MC. Patterns of dietary supplement use for weight loss among US adults with obesity: NHANES 2007–2020. J Obesity 2026; Article ID 6761414.
Poster #1411: Major Depressive Episode and Depression Treatment Among Adolescents and Young Adults With vs. Without a Cancer History in the United States, 2021–2024. Direct link: https://www.accp.com/abstracts/posters.aspx?mc=26VPS&sid=1411
Poster #1412: Trends in Weight-Loss Attempts, Strategies, and Clinically Meaningful Weight Loss Among U.S. Adults With Hypertension and Overweight or Obesity, NHANES 1999–2023. Direct link: https://www.accp.com/abstracts/posters.aspx?mc=26VPS&sid=1412
Poster #1413: Substance Use Patterns and Correlates of Polysubstance Use Among People Living With HIV in the National Survey on Drug Use and Health, 2021–2024. Direct link: https://www.accp.com/abstracts/posters.aspx?mc=26VPS&sid=1413.
Dr. Liu was also awarded a research grant of $9,990 from ASHP Foundation for his proposal, "Improving Access to Safe and Effective GLP-1 Therapy Use Through a Pharmacist-Led Skills Check." Dr. Liu is leading this project to develop and pilot a pharmacist-led GLP-1 Skills Check to help patients correctly administer and store GLP-1 receptor agonists and related injectable medications. The study will identify common injection and storage errors, provide targeted pharmacist teach-back education, and evaluate whether this service improves patient confidence and promotes safe medication use over time. The long-term goal is to expand access to practical pharmacist support and improve outcomes for patients using these therapies.
|